Navigation Links
Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications
Date:6/29/2009

a, "In just over a year from incorporation in Hong Kong, Pangu BioPharma has demonstrated how well the government, university and industry partnership works. In that short time, with the support of HKUST and funding from the ITC, we have attracted a highly skilled group of scientists, established a well quipped lab at HKUST with the latest technology, and built an IP generating platform at the Pangu BioPharma operations that has already yielded data to support three new patent applications. These inventions are key components of aTyr Pharma's product generating engine, and are proof of the strong support Pangu BioPharma receives from the Hong Kong government and HKUST."

Professor Paul Schimmel of The Scripps Research Institute is a visiting scholar at the Institute of Advanced Science at HKUST and a co-founder of aTyr Pharma as well as Pangu BioPharma. Professor Schimmel was the driver behind building the partnership between aTyr and HKUST. An expert on tRNA synthetases, Paul Schimmel has also been the co-founder or founding director of numerous successful biotechnology companies, including Sirtris Pharmaceuticals, Alnylam, Repligen Corporation, Alkermes, Inc., Momenta Pharmaceuticals and Cubist Pharmaceuticals, which were taken public on the NASDAQ and are well established as companies that develop and market new medicines. "This is an exciting time to launch a biotechnology endeavor in Hong Kong. The government and university system in Hong Kong have a powerful vision to translate their strengths in research into a thriving biotechnology industry that opens the door to the valuable resources of China. aTyr Pharma and Pangu BioPharma are at the forefront of this effort and are pleased to have the ITC and HKUST as partners. We particularly value the contributions of Professors Mingjie Zhang and Nancy Ip of the Biochemistry Department at HKUST, as well as Matthew Yuen of HKUST's Research and Development group," says Professor Schi
'/>"/>

SOURCE aTyr Pharma
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck
2. DOR BioPharma, Inc. Executes $400,000 Equity Investment Agreement With Numoda Corporation
3. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
4. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
5. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
6. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
7. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
8. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
9. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
10. Pharmasset Reports First Fiscal Quarter 2008 Financial Results
11. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Inc., developer and marketer of the VerifyNow® System, ... measuring an individual,s response to multiple antiplatelet agents, ... number of international and U.S. distribution agreements, as ... capital financing that will take the company into ... its commitment to creating a powerful, worldwide distribution ...
(Date:12/14/2009)... The 2009 Frost & Sullivan European ... is conferred on SonoScape. The award recipient has ... for special features, pricing, and portability - and ... performance of this high-end colour Doppler HCU compares ... ultrasound system. ,, (Logo: ...
(Date:12/14/2009)... Dec. 14 Fujirebio Diagnostics Inc., a ... of the Year by the Eastern Technology Council ... Hotel in Philadelphia on Thursday, December 3, 2009. ... the Philadelphia region,s largest technology and life sciences ... the Technology and Life Sciences Community, the awards ...
Breaking Medicine Technology:Accumetrics Closes 2009 with Positive Outlook 2Accumetrics Closes 2009 with Positive Outlook 3Frost & Sullivan Product Quality Leadership Award in the European Ultrasound Market Conferred on SonoScape for S8 2Frost & Sullivan Product Quality Leadership Award in the European Ultrasound Market Conferred on SonoScape for S8 3Fujirebio Diagnostics Named Life Sciences Company of the Year 2UPS Chief Named to U S Fund for UNICEFs Board of Directors 57267 1UPS Chief Named to U S Fund for UNICEFs Board of Directors 57267 2Poll 3A Liberals Oppose Healthcare for Illegal Aliens 57265 1Poll 3A Liberals Oppose Healthcare for Illegal Aliens 57265 23rd Annual Collaborative Drug Discovery UCSF Community Meeting for Catalyzing Humanitarian and Commercial Research to be Held October 1st 57263 13rd Annual Collaborative Drug Discovery UCSF Community Meeting for Catalyzing Humanitarian and Commercial Research to be Held October 1st 57263 23rd Annual Collaborative Drug Discovery UCSF Community Meeting for Catalyzing Humanitarian and Commercial Research to be Held October 1st 57263 33rd Annual Collaborative Drug Discovery UCSF Community Meeting for Catalyzing Humanitarian and Commercial Research to be Held October 1st 57263 4
(Date:12/15/2009)... Ga., Dec. 15 Hosted by the ... 4th annual event recognized 2009,s best eLearning designs. ... were spread across 4 categories. The Venza ... for the world,s largest hotelier, was selected as ... of Custom eLearning" category by the panel of ...
(Date:12/15/2009)... fatty acid synthesis in brain cancer cells may offer ... deadly glioblastomas that are driven by amplified signaling of ... first-of-its-kind study by researchers at UCLA,s Jonsson Comprehensive Cancer ... for the formation of new membranes. The fatty acids ... cells, and may be important for regulating cell signaling, ...
(Date:12/15/2009)... team of Canadian and Spanish scientists have found the ... severe pneumonia when infected by the pandemic H1N1 virus. ... molecules for 20 hospitalized patients, 15 outpatients and 15 ... pandemic wave in July and August 2009. Researchers from ... the University Health Network found high levels of a ...
(Date:12/15/2009)... about-face, the secretive Central Intelligence Agency has requested documents from ... them from the CIA itself under the Freedom of Information ... ... 15, 2009 -- In a bizarre about-face, the secretive Central ... though the writer had earlier obtained them from the CIA ...
(Date:12/15/2009)... for those with the virus, expert says , , TUESDAY, ... Switzerland who were infected with HIV decreased by more ... therapy in 1996, a new study shows. , HIV ... the decrease, the suicide rate among those infected with ... population, according to the study, led by Olivia Keiser, ...
Breaking Medicine News(10 mins):Health News:The Venza Group Received Top Honors at the American Society of Training & Development (ASTD) eLearning Excellence Awards Ceremony Held on December 10, 2009 2Health News:Targeting brain cancer cell metabolism may provide new treatment 2Health News:Targeting brain cancer cell metabolism may provide new treatment 3Health News:First immunological clue to why some H1N1 patients get very ill or die 2Health News:CIA Requests its Own Documents from Author 2Health News:CIA Requests its Own Documents from Author 3Health News:HIV Therapy Linked to Fewer Suicides 2
... study provides doctors with guidelines on when to repeat ... , International clinical guidelines on the matter are ... a serious condition like osteoporosis, affecting millions, it is ... and Dr Nguyen Nguyen from the Garvan Institute of ...
... Workforce BERKELEY, Calif. and OAKLAND, Calif., May 12 ... today the Kaiser Permanente Community Health Scholars Program, an ambitious ... public health workers. Funded by a $5 million grant from ... East Bay Community Foundation, the program - to be based ...
... treatments, local gyms and fresh food among barriers preventing ... habits to take control of their diabetes INDIANAPOLIS, ... a not-for-profit organization dedicated to informing and empowering people ... health care, announced findings today from a recent survey ...
... a Leader in Supporting the CommunityPORTLAND, Ore., May 12 ... and women, is actively involved in keeping Portland a ... raise money for charitable auctions, making cash donations to ... drives for women,s and children,s shelters, partnering with other ...
... professionals and families caring for seniors to screen ground-breaking ... Living (NYSE: SRZ ) communities will host ... Project to encourage greater awareness about the disease ... Locate a local Sunrise community by going to ...
... Both Ventricles with the Total Artificial Heart ,Eliminates Complications Including ... ... Ariz. (Vocus) May 12, 2009 -- According to INTERMACS data ... SynCardia temporary CardioWest™ Total Artificial Heart has a bridge-to-transplant rate ...
Other Medicine News:Health News:When to get your bone density measured -- that is the question 2Health News:UC Berkeley Launches Kaiser Permanente Community Health Scholars Program 2Health News:UC Berkeley Launches Kaiser Permanente Community Health Scholars Program 3Health News:Indianapolis Residents View Economic Challenges as Significant Barrier to Properly Managing Type 2 Diabetes 2Health News:Indianapolis Residents View Economic Challenges as Significant Barrier to Properly Managing Type 2 Diabetes 3Health News:Indianapolis Residents View Economic Challenges as Significant Barrier to Properly Managing Type 2 Diabetes 4Health News:Bishops Barbershop - Keeping Portland a Great Place to Live 2Health News:Sunrise Senior Living Communities to Show HBO's The Alzheimer's Project 2Health News:Sunrise Senior Living Communities to Show HBO's The Alzheimer's Project 3Health News:INTERMACS: Total Artificial Heart Bridge-to-Transplant Rate 2x Higher ,at 6 Months Than BiVADS and LVADs 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: